Compare Amylx Pharmaceuticals Inc (AMLX) vs Hilton Hotels Corporation Common Stock (HLT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs Hilton Hotels Corporation Common Stock — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Hilton Hotels Corporation Common Stock trades at $318 (market cap $70.82B). The key difference: Hilton Hotels Corporation Common Stock is far larger — about 26.8× Amylx Pharmaceuticals Inc's market cap, and Hilton Hotels Corporation Common Stock pays a 0.19% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | HLT | |
|---|---|---|
Market Cap | $2.64B | $70.82B |
Sector | Health | Consumer Cyclical |
52-Week High | $24.19 | $350.22 |
52-Week Low | $7.82 | $256.75 |
Enterprise Value | $2.39B | $83.83B |
Dividend Yield | — | 0.19% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About Hilton Hotels Corporation Common Stock
Hilton Worldwide Holdings operates 1,074,791 rooms across its 18 brands addressing the midscale through luxury segments as of Dec. 31, 2021. Hampton and Hilton are the two largest brands by total room count at 28% and 21%, respectively, as of Dec. 31, 2021. Recent brands launched over the last few years include Home2, Curio, Canopy, Tru, and Tempo. Managed and franchised represent the vast majority of adjusted EBITDA, predominantly from the Americas regions.
Read more on HLT →
